Lineage Cell Therapeutics In shares owned by Citadel Advisors
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $645k | 592k | 1.09 |
| 2023-09-30 | $487k | 413k | 1.18 |
| 2023-06-30 | $577k | 409k | 1.41 |
| 2023-03-31 | $409k | 272k | 1.50 |
| 2022-12-31 | $171k | 146k | 1.17 |
| 2022-06-30 | $55k | 35k | 1.58 |
| 2022-03-31 | $149k | 97k | 1.54 |
| 2021-12-31 | $746k | 305k | 2.45 |
| 2021-09-30 | $428k | 170k | 2.52 |
| 2021-06-30 | $411k | 143k | 2.87 |
| 2021-03-31 | $674k | 281k | 2.39 |
| 2020-12-31 | $76k | 43k | 1.78 |
| 2020-06-30 | $110k | 127k | 0.87 |
| 2020-03-31 | $67k | 80k | 0.83 |
| 2019-12-31 | $85k | 95k | 0.89 |
| 2019-09-30 | $39k | 39k | 0.99 |